Claudio Villanueva, PhD
- Departments: Biochemistry - Assistant Professor
Academic Office Information
Emma Eccles Jones Medical Research Building
15 N Medical Dr E, Room: 5800K
Salt Lake City, UT
The research objectives of my laboratory are to investigate the transcriptional mechanisms that regulate adipocyte development and biology. Our work is beginning to unravel the molecular mechanisms that distinguish between the white, brown, and beige adipocyte subtypes. We are finding that the combinatorial actions of PPARγ coactivators TLE3 and Prdm16 are key to establishing the phenotypic characteristics of adipocyte subtypes. Because brown and beige adipocytes consume carbohydrates and lipids when activated, we hope to understand how their metabolic program is regulated to identify new strategies to treat diabetes. I have had extraordinary mentoring and research training through my academic career and have gained expertise in endocrinology, genetics, physiology, lipid biochemistry, transcription, and cellular and molecular biology. As a Ph.D. student at UCSF I studied in the laboratory of Robert Farese Jr. M.D. at the Gladstone Institute of Cardiovascular Disease where I investigated an enzyme (DGAT1) that catalyzes the final step in triglyceride biosynthesis and studied its role in hepatic lipid metabolism in mice. The exceptional training acquired at UCSF led to my postdoctoral training at UCLA in the laboratory of Peter Tontonoz M.D., Ph.D., an HHMI investigator that investigates nuclear receptor biology and metabolism. The current application builds logically from my prior work, and I have chosen collaborators who will provide additional expertise in mouse phenotyping studies, protein expression and purification, and cellular energetics.
|Postdoctoral Fellowship||Howard Hughes Medical Institute, University of California Los Angeles
|Doctoral Training||Gladstone Institute of Cardiovascular Disease, University of California
|Undergraduate||California State University
- Drew BG, Hamidi H, Zhou Z, Villanueva CJ, Krum SA, Calkin AC, Parks BW, Ribas V, Kalajian NY, Phun J, Daraei P, Christofk HR, Hewitt SC, Korach KS, Tontonoz P, Lusis AJ, Slamon DJ, Hurvitz SA, Hevener AL (2015). Estrogen receptor (ER)alpha-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression. J Biol Chem, 290(9), 5566-81.
- Drew BG, Hamidi H, Zhou Z, Villanueva CJ, Krum SA, Calkin AC, Parks BW, Ribas V, Kalajian NY, Phun J, Daraei P, Christofk HR, Hewitt SC, Korach KS, Tontonoz P, Lusis AJ, Slamon DJ, Hurvitz SA, Hevener AL (2014). ERα-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression. J Biol Chem.
- Villanueva CJ, Vergnes L, Wang J, Drew BG, Hong C, Tu Y, Hu Y, Peng X, Xu F, Saez E, Wroblewski K, Hevener AL, Reue K, Fong LG, Young SG, Tontonoz P (2013). Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARgamma specifies lipid storage versus thermogenic gene programs. Cell Metab, 17(3), 423-35.
- Zhang Q, Ramlee MK, Brunmeir R, Villanueva CJ, Halperin D, Xu F (2012). Dynamic and distinct histone modifications modulate the expression of key adipogenesis regulatory genes. Cell Cycle, 11(23), 4310-22.
- Villanueva CJ, Waki H, Godio C, Nielsen R, Chou WL, Vargas L, Wroblewski K, Schmedt C, Chao LC, Boyadjian R, Mandrup S, Hevener A, Saez E, Tontonoz P (2011). TLE3 is a dual-function transcriptional coregulator of adipogenesis. Cell Metab, 13(4), 413-27.
- Villanueva CJ, Tontonoz P (2010). Licensing PPARgamma to work in macrophages. Immunity, 33(5), 647-9.